These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14614012)

  • 1. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
    Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
    Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
    Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
    J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients.
    Fujitake S; Hibi K; Okochi O; Kodera Y; Ito K; Akiyama S; Nakao A
    J Gastroenterol; 2004; 39(2):120-4. PubMed ID: 15074307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
    Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG
    Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
    Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
    Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
    Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
    Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
    To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
    Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley.
    Hussain S; Singh N; Salam I; Bandil K; Yuvaraj M; Akbar Bhat M; Muzaffar Mir M; Siddiqi MA; Sobti RC; Bharadwaj M; Das BC
    J Recept Signal Transduct Res; 2011 Apr; 31(2):147-56. PubMed ID: 21385099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
    Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma.
    Galm O; Yoshikawa H; Esteller M; Osieka R; Herman JG
    Blood; 2003 Apr; 101(7):2784-8. PubMed ID: 12456503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
    Yang B; Guo M; Herman JG; Clark DP
    Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
    Fukushima N; Sato N; Sahin F; Su GH; Hruban RH; Goggins M
    Br J Cancer; 2003 Jul; 89(2):338-43. PubMed ID: 12865927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
    Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
    J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
    Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
    Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma.
    Ko E; Kim SJ; Joh JW; Park CK; Park J; Kim DH
    Cancer Lett; 2008 Nov; 271(2):240-50. PubMed ID: 18639978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers.
    Komazaki T; Nagai H; Emi M; Terada Y; Yabe A; Jin E; Kawanami O; Konishi N; Moriyama Y; Naka T; Kishimoto T
    Jpn J Clin Oncol; 2004 Apr; 34(4):191-4. PubMed ID: 15121754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis.
    Yoshida T; Ogata H; Kamio M; Joo A; Shiraishi H; Tokunaga Y; Sata M; Nagai H; Yoshimura A
    J Exp Med; 2004 Jun; 199(12):1701-7. PubMed ID: 15197228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
    Watanabe D; Ezoe S; Fujimoto M; Kimura A; Saito Y; Nagai H; Tachibana I; Matsumura I; Tanaka T; Kanegane H; Miyawaki T; Emi M; Kanakura Y; Kawase I; Naka T; Kishimoto T
    Br J Haematol; 2004 Sep; 126(5):726-35. PubMed ID: 15327527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
    He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
    Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.